Alyeska Investment Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-40,028
Closed -$1.33M 510
2017
Q1
$1.33M Buy
+40,028
New +$1.33M 0.01% 408